https://www.sciencedaily.com/news/health_medicine/chronic_fatigue_syndrome/ Chronic fatigue syndrome. Read the latest research news on chronic fatigue syndrome (CFS). en-us Sun, 19 Apr 2026 00:01:54 EDT Sun, 19 Apr 2026 00:01:54 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/chronic_fatigue_syndrome/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260414075650.htm Scientists have taken a major step toward stopping Epstein-Barr virus (EBV), an extremely common infection linked to cancer and chronic disease. By using mice engineered with human antibody genes, researchers created powerful human-like antibodies that block the virus from attaching to and entering immune cells. One of these antibodies completely prevented infection in lab models with human immune systems, marking a breakthrough after years of difficulty tackling EBV’s ability to invade nearly all B cells. Wed, 15 Apr 2026 03:26:50 EDT https://www.sciencedaily.com/releases/2026/04/260414075650.htm https://www.sciencedaily.com/releases/2026/03/260331001107.htm A surprising breakthrough suggests that a drug best known as Viagra could help treat a devastating childhood disease. Researchers found that sildenafil significantly improved symptoms in patients with Leigh syndrome—a rare and often fatal disorder that affects the brain and muscles. In a small study, patients showed stronger muscles, fewer seizures, and better recovery from dangerous metabolic crises, with some experiencing dramatic improvements in mobility and daily life. Tue, 31 Mar 2026 08:33:45 EDT https://www.sciencedaily.com/releases/2026/03/260331001107.htm https://www.sciencedaily.com/releases/2026/03/260328043558.htm Scientists have developed a new gene therapy that quiets pain at its source in the brain—without the addictive risks of opioids. Using AI to map how pain is processed, they created a targeted “off switch” that mimics morphine’s benefits but skips its dangerous side effects. In early tests, it delivered lasting relief without affecting normal sensations. The discovery could mark a major step toward safer, non-addictive pain treatments. Sat, 28 Mar 2026 20:57:04 EDT https://www.sciencedaily.com/releases/2026/03/260328043558.htm https://www.sciencedaily.com/releases/2026/03/260323005542.htm A new study suggests a widely used bone hormone could help relieve chronic back pain in an unexpected way. Instead of just strengthening bone, it appears to stop pain-sensing nerves from growing into damaged spinal areas. In animal models, this led to stronger spinal tissue and reduced pain sensitivity. The findings hint at a future treatment that tackles back pain at its biological roots. Mon, 23 Mar 2026 22:28:06 EDT https://www.sciencedaily.com/releases/2026/03/260323005542.htm https://www.sciencedaily.com/releases/2026/03/260317015933.htm mRNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA nanostructures to better control how the immune system responds. In early studies, it produced strong antibody and T cell responses in both mice and human models. Researchers say it could lead to more stable, easier-to-manufacture vaccines for diseases like COVID-19, HIV, and Ebola. Tue, 17 Mar 2026 01:59:33 EDT https://www.sciencedaily.com/releases/2026/03/260317015933.htm https://www.sciencedaily.com/releases/2026/03/260306145621.htm Researchers have discovered a new way to increase a key brain protein damaged in Rett syndrome, a rare genetic disorder that affects thousands of children worldwide. Early studies in mice and patient-derived cells show the approach can restore normal brain cell function, raising hopes for future therapies. Fri, 06 Mar 2026 21:18:09 EST https://www.sciencedaily.com/releases/2026/03/260306145621.htm https://www.sciencedaily.com/releases/2026/01/260131084610.htm Statins are a cornerstone of heart health, but muscle pain and weakness cause many patients to quit taking them. Scientists have now identified the precise molecular trigger behind these side effects. They found that statins jam open a critical muscle protein, causing a toxic calcium leak. The discovery could lead to safer statins that keep their life-saving benefits without the muscle damage. Sat, 31 Jan 2026 10:39:49 EST https://www.sciencedaily.com/releases/2026/01/260131084610.htm https://www.sciencedaily.com/releases/2026/01/260114084122.htm A new discovery may explain why so many people abandon cholesterol-lowering statins because of muscle pain and weakness. Researchers found that certain statins can latch onto a key muscle protein and trigger a tiny but harmful calcium leak inside muscle cells. That leak may weaken muscles directly or activate processes that slowly break them down, offering a long-sought explanation for statin-related aches. Wed, 14 Jan 2026 11:06:53 EST https://www.sciencedaily.com/releases/2026/01/260114084122.htm https://www.sciencedaily.com/releases/2026/01/260107225532.htm Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system long after infection. Researchers now link symptoms to lingering virus, inflammation, micro-clots, and disrupted energy metabolism. While structured rehab and pacing can improve quality of life, a growing list of experimental treatments—from antivirals and metformin to microbiome therapies and biologics—shows early promise. Clear answers, however, are still limited by small studies and the lack of large, definitive trials. Thu, 08 Jan 2026 19:57:41 EST https://www.sciencedaily.com/releases/2026/01/260107225532.htm https://www.sciencedaily.com/releases/2026/01/260106224628.htm Researchers have reconstructed ancient herpesvirus genomes from Iron Age and medieval Europeans, revealing that HHV-6 has been infecting humans for at least 2,500 years. Some people inherited the virus directly in their DNA, passing it down across generations. The study shows that these viruses evolved alongside humans—and that one strain eventually lost its ability to integrate into our chromosomes. It’s the first time this long, intimate relationship has been proven with ancient genetic evidence. Wed, 07 Jan 2026 07:07:41 EST https://www.sciencedaily.com/releases/2026/01/260106224628.htm https://www.sciencedaily.com/releases/2025/12/251225080723.htm Tramadol, a popular opioid often seen as a “safer” painkiller, may not live up to its reputation. A large analysis of clinical trials found that while it does reduce chronic pain, the relief is modest—so small that many patients likely wouldn’t notice much real-world benefit. At the same time, tramadol was linked to a significantly higher risk of serious side effects, especially heart-related problems like chest pain and heart failure, along with common issues such as nausea, dizziness, and sleepiness. Thu, 25 Dec 2025 11:52:44 EST https://www.sciencedaily.com/releases/2025/12/251225080723.htm https://www.sciencedaily.com/releases/2025/12/251214100940.htm Back pain is wrapped in persistent myths, but many are far from the truth. From misconceptions about heavy lifting and bed rest to confusion over posture, exercise, and surgery, Dr. Meghan Murphy breaks down what really causes pain and what actually helps. Her insights reveal that everyday habits, movement, and smart prevention often make a bigger difference than people realize. Mon, 15 Dec 2025 01:55:23 EST https://www.sciencedaily.com/releases/2025/12/251214100940.htm https://www.sciencedaily.com/releases/2025/12/251213032615.htm Researchers used a deep learning AI model to uncover the first imaging-based biomarker of chronic stress by measuring adrenal gland volume on routine CT scans. This new metric, the Adrenal Volume Index, correlates strongly with cortisol levels, allostatic load, perceived stress, and even long-term cardiovascular outcomes, including heart failure risk. Sun, 14 Dec 2025 09:27:30 EST https://www.sciencedaily.com/releases/2025/12/251213032615.htm https://www.sciencedaily.com/releases/2025/11/251125112506.htm Scientists discovered that more muscle and less hidden abdominal fat are linked to a younger biological brain age. Deep visceral fat appeared to accelerate brain aging, while muscle mass offered a protective effect. Tue, 25 Nov 2025 11:34:58 EST https://www.sciencedaily.com/releases/2025/11/251125112506.htm https://www.sciencedaily.com/releases/2025/11/251124075330.htm A research team has found that specific immune cells can connect with muscle fibers in a lightning-fast, neuron-like way to promote healing. These cells deliver quick pulses of calcium, triggering repair within seconds. The mechanism works in both injury and disease models. The discovery could inspire new treatments for muscle recovery and degeneration. Mon, 24 Nov 2025 08:06:04 EST https://www.sciencedaily.com/releases/2025/11/251124075330.htm https://www.sciencedaily.com/releases/2025/11/251117095639.htm Chronic pain might quietly push people toward developing high blood pressure—and the more widespread the pain, the greater the danger. A massive analysis of over 200,000 adults uncovered strong links between long-lasting pain, depression, inflammation, and rising hypertension risk. Mon, 17 Nov 2025 22:42:19 EST https://www.sciencedaily.com/releases/2025/11/251117095639.htm https://www.sciencedaily.com/releases/2025/11/251110021041.htm Scientists have discovered that most chronic fatigue patients experience dysfunctional breathing, which may worsen their symptoms. The likely culprit is dysautonomia, a disruption in how the body controls blood vessels and muscles. Breathing retraining, yoga, or biofeedback could help restore proper breathing rhythm and ease fatigue. The findings open a promising new path for managing this long-misunderstood illness. Mon, 10 Nov 2025 05:47:39 EST https://www.sciencedaily.com/releases/2025/11/251110021041.htm https://www.sciencedaily.com/releases/2025/11/251104013027.htm Using powerful 7-Tesla brain imaging, researchers mapped how the brainstem manages pain differently across the body. They discovered that distinct regions activate for facial versus limb pain, showing the brain’s built-in precision pain control system. The findings could lead to targeted, non-opioid treatments that use cannabinoid mechanisms instead of opioids, offering safer pain relief options. Tue, 04 Nov 2025 05:36:11 EST https://www.sciencedaily.com/releases/2025/11/251104013027.htm https://www.sciencedaily.com/releases/2025/11/251102205021.htm A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve faced doubt and misdiagnosis, it’s a breakthrough that finally validates their experience — and may help diagnose long Covid too. Mon, 03 Nov 2025 02:22:12 EST https://www.sciencedaily.com/releases/2025/11/251102205021.htm https://www.sciencedaily.com/releases/2025/10/251019120527.htm Scientists have found that preserving lymph nodes during cancer surgery could dramatically improve how patients respond to immunotherapy. The research shows that lymph nodes are essential for training and sustaining cancer-fighting T cells. Removing them may unintentionally weaken the immune response, while keeping them intact could help unlock stronger, longer-lasting treatments. Mon, 20 Oct 2025 07:48:10 EDT https://www.sciencedaily.com/releases/2025/10/251019120527.htm https://www.sciencedaily.com/releases/2025/10/251015032318.htm Scientists discovered that lean pork builds muscle more effectively post-workout than high-fat pork, even with identical protein levels. Using advanced tracking techniques, they found that fat content blunted the body’s muscle-building response. The results contradict previous findings about fattier foods enhancing synthesis, suggesting that food form and processing matter. Wed, 15 Oct 2025 11:02:33 EDT https://www.sciencedaily.com/releases/2025/10/251015032318.htm https://www.sciencedaily.com/releases/2025/10/251009033126.htm Scientists have pinpointed Y1 receptor neurons in the brain that can override chronic pain signals when survival instincts like hunger or fear take precedence. Acting like a neural switchboard, these cells balance pain with other biological needs. The research could pave the way for personalized treatments that target pain at its brain source—offering hope for millions living with long-term pain. Fri, 10 Oct 2025 06:16:16 EDT https://www.sciencedaily.com/releases/2025/10/251009033126.htm https://www.sciencedaily.com/releases/2025/10/251002073959.htm Penn researchers found that psilocybin can calm brain circuits tied to pain and mood, easing both physical suffering and emotional distress in animal studies. The compound works in the anterior cingulate cortex, bypassing injury sites and offering a dual benefit for pain and depression. Unlike opioids, psilocybin is non-addictive and may provide relief lasting weeks. Thu, 02 Oct 2025 09:10:21 EDT https://www.sciencedaily.com/releases/2025/10/251002073959.htm https://www.sciencedaily.com/releases/2025/09/250926035030.htm Scientists have discovered a way to block pain while still allowing the body’s natural healing to take place. Current painkillers like ibuprofen and aspirin often come with harmful side effects because they shut down both pain and inflammation. But this new research identified a single “pain switch” receptor that can be turned off without interfering with inflammation, which actually helps the body recover. Fri, 26 Sep 2025 19:56:30 EDT https://www.sciencedaily.com/releases/2025/09/250926035030.htm https://www.sciencedaily.com/releases/2025/08/250818102944.htm A sweeping review of 67 trials has cast doubt on the use of ketamine and similar NMDA receptor antagonists for chronic pain relief. While ketamine is frequently prescribed off-label for conditions like fibromyalgia and nerve pain, researchers found little convincing evidence of real benefit and flagged serious side effects such as delusions and nausea. The lack of data on whether it reduces depression or opioid use adds to the uncertainty. Mon, 18 Aug 2025 23:32:20 EDT https://www.sciencedaily.com/releases/2025/08/250818102944.htm https://www.sciencedaily.com/releases/2025/07/250730030358.htm Stepping into a virtual forest or waterfall scene through VR could be the future of pain management. A new study shows that immersive virtual nature dramatically reduces pain sensitivity almost as effectively as medication. Researchers at the University of Exeter found that the more present participants felt in these 360-degree nature experiences, the stronger the pain-relieving effects. Brain scans confirmed that immersive VR scenes activated pain-modulating pathways, revealing that our brains can be coaxed into suppressing pain by simply feeling like we re in nature. Wed, 30 Jul 2025 03:03:58 EDT https://www.sciencedaily.com/releases/2025/07/250730030358.htm https://www.sciencedaily.com/releases/2025/07/250710113151.htm What if your brain is the reason some pain feels unbearable? Scientists at the Salk Institute have discovered a hidden brain circuit that gives pain its emotional punch—essentially transforming ordinary discomfort into lasting misery. This breakthrough sheds light on why some people suffer more intensely than others from conditions like fibromyalgia, migraines, and PTSD. By identifying the exact group of neurons that link physical pain to emotional suffering, the researchers may have found a new target for treating chronic pain—without relying on addictive medications. Thu, 10 Jul 2025 23:37:05 EDT https://www.sciencedaily.com/releases/2025/07/250710113151.htm https://www.sciencedaily.com/releases/2025/07/250706230311.htm When you're mentally exhausted, your brain might be doing more behind the scenes than you think. In a new study using functional MRI, researchers uncovered two key brain regions that activate when people feel cognitively fatigued—regions that appear to weigh the cost of continuing mental effort versus giving up. Surprisingly, participants needed high financial incentives to push through challenging memory tasks, hinting that motivation can override mental fatigue. These insights may pave the way to treating brain fog in disorders like PTSD and depression using brain imaging and behavior-based therapies. Mon, 07 Jul 2025 04:34:10 EDT https://www.sciencedaily.com/releases/2025/07/250706230311.htm https://www.sciencedaily.com/releases/2025/06/250630073443.htm Scientists have discovered a stealthy mechanism that cytomegalovirus (CMV)—the leading infectious cause of birth defects in the U.S.—uses to infiltrate blood vessel cells while evading immune detection. The virus forms a hidden protein complex that acts like a molecular “backdoor,” allowing it to bypass the immune system’s defenses. This newly identified pathway may explain why vaccine efforts have failed for decades and opens the door to targeted therapies that could finally prevent CMV-linked birth defects in newborns and protect vulnerable patients. Mon, 30 Jun 2025 23:40:17 EDT https://www.sciencedaily.com/releases/2025/06/250630073443.htm https://www.sciencedaily.com/releases/2025/06/250623233327.htm A groundbreaking wireless implant promises real-time, personalized pain relief using AI and ultrasound power no batteries, no wires, and no opioids. Designed by USC and UCLA engineers, it reads brain signals, adapts on the fly, and bends naturally with your spine. Tue, 24 Jun 2025 02:38:14 EDT https://www.sciencedaily.com/releases/2025/06/250623233327.htm https://www.sciencedaily.com/releases/2025/06/250620231852.htm USC researchers have uncovered a hidden driver behind the early and severe onset of Alzheimer's in people with Down syndrome: iron overload in the brain. Their study revealed that individuals with both conditions had twice the iron levels and far more oxidative damage than others. The culprit appears to be ferroptosis, an iron-triggered cell death mechanism, which is especially damaging in sensitive brain regions. Fri, 20 Jun 2025 23:18:52 EDT https://www.sciencedaily.com/releases/2025/06/250620231852.htm https://www.sciencedaily.com/releases/2025/06/250619090853.htm Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response with just one dose. By combining two immune-boosting adjuvants alum and SMNP the vaccine lingers in lymph nodes for nearly a month, encouraging the body to produce a vast array of antibodies. This one-shot strategy could revolutionize how we fight not just HIV, but many infectious diseases. It mimics the natural infection process and opens the door to broadly neutralizing antibody responses, a holy grail in vaccine design. And best of all, it's built on components already known to medicine. Thu, 19 Jun 2025 09:08:53 EDT https://www.sciencedaily.com/releases/2025/06/250619090853.htm https://www.sciencedaily.com/releases/2025/06/250603115020.htm Researchers asked patients, some of whom had experienced lower back pain for up to 40 years, if being in nature helped them coped better with their lower back pain. They found that people able to spend time in their own gardens saw some health and wellbeing benefits. However, those able to immerse themselves in larger green spaces such as forests felt even more positive, as they were able to lose themselves in the environment and focus more on that than their pain levels. The researchers have recommended trying to incorporate time spent in nature into people's treatments plans, and are also using their findings to develop virtual reality interventions that allow people to experience some of the benefits of being in nature without the need to travel anywhere if they are unable to do so. Tue, 03 Jun 2025 11:50:20 EDT https://www.sciencedaily.com/releases/2025/06/250603115020.htm https://www.sciencedaily.com/releases/2025/06/250602155330.htm A trial of an interactive game that trains people to alter their brain waves has shown promise as a treatment for nerve pain -- offering hope for a new generation of drug-free treatments. Mon, 02 Jun 2025 15:53:30 EDT https://www.sciencedaily.com/releases/2025/06/250602155330.htm https://www.sciencedaily.com/releases/2025/05/250520121149.htm Middle-aged and older adults who experience pain are more likely to have had worsening symptoms of depression up to eight years before the pain began, according to a new study. Tue, 20 May 2025 12:11:49 EDT https://www.sciencedaily.com/releases/2025/05/250520121149.htm https://www.sciencedaily.com/releases/2025/05/250516134541.htm Psychological treatment can relieve pain. New research now shows what happens in the brain -- and what specific treatments psychologists, doctors and patients can turn to. Fri, 16 May 2025 13:45:41 EDT https://www.sciencedaily.com/releases/2025/05/250516134541.htm https://www.sciencedaily.com/releases/2025/05/250515132119.htm Palliative care is specialized medical care focused on easing symptoms, addressing psychological and spiritual needs, and helping patients and caregivers make critical decisions aligned with their personal beliefs and values. Thu, 15 May 2025 13:21:19 EDT https://www.sciencedaily.com/releases/2025/05/250515132119.htm https://www.sciencedaily.com/releases/2025/05/250514164333.htm A transient ischemic attack, also known as a mini-stroke, is typically defined as a temporary blockage of blood flow to the brain that causes symptoms that go away within a day, but a new study finds that people who have this type of stroke may also have prolonged fatigue lasting up to one year. Wed, 14 May 2025 16:43:33 EDT https://www.sciencedaily.com/releases/2025/05/250514164333.htm https://www.sciencedaily.com/releases/2025/05/250513112146.htm Researchers have identified a never-before-seen mechanism that enables HIV-1 to evade the body's natural defenses and use it to support its survival and replication. The 'loophole' is a biological process that involves circular RNAs and marks the first experimental evidence of HIV-1 generating them from an integrated retroviral genome. Findings point to a novel strategy the virus uses to survive, providing a new target in the fight against one of the world's most resilient pathogens. Tue, 13 May 2025 11:21:46 EDT https://www.sciencedaily.com/releases/2025/05/250513112146.htm https://www.sciencedaily.com/releases/2025/05/250512165549.htm Researchers confirm and explore the role of estrogen-related receptors in regulating energy production in muscle cells during exercise. The findings indicate that developing a drug to boost estrogen-related receptors could be a powerful way to restore energy supplies in people with metabolic disorders, such as muscular dystrophy. Mon, 12 May 2025 16:55:49 EDT https://www.sciencedaily.com/releases/2025/05/250512165549.htm https://www.sciencedaily.com/releases/2025/05/250508172454.htm Scientists have developed a cortical organoid model for UBA5-associated encephalopathy, revealing a new way to possibly address developmental defects. Thu, 08 May 2025 17:24:54 EDT https://www.sciencedaily.com/releases/2025/05/250508172454.htm https://www.sciencedaily.com/releases/2025/05/250506131322.htm Researchers have created an effective therapy for chronic pain that reduces pain intensity by focusing on emotional regulation. Tue, 06 May 2025 13:13:22 EDT https://www.sciencedaily.com/releases/2025/05/250506131322.htm https://www.sciencedaily.com/releases/2025/05/250505170657.htm Muscle cells contain their own circadian clocks and disrupting them with shift work can have a profound impact on aging, according to new research. Mon, 05 May 2025 17:06:57 EDT https://www.sciencedaily.com/releases/2025/05/250505170657.htm https://www.sciencedaily.com/releases/2025/04/250428221209.htm Where you get your vaccine booster matters more than you think. Scientists in Sydney found that same-arm shots prime immune cells to respond faster, producing stronger antibodies against viruses like COVID-19 in the first week. This early edge could be crucial during outbreaks, giving people protection when it matters most. Mon, 28 Apr 2025 22:12:09 EDT https://www.sciencedaily.com/releases/2025/04/250428221209.htm https://www.sciencedaily.com/releases/2025/04/250425113441.htm A new study provides new evidence that sensory stimulation of a gamma-frequency brain rhythm may promote broad-based restorative neurological health response. Fri, 25 Apr 2025 11:34:41 EDT https://www.sciencedaily.com/releases/2025/04/250425113441.htm https://www.sciencedaily.com/releases/2025/04/250422131531.htm A newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been caught between existing classification systems, marking the first major discovery of its kind in 45 years. 'Oligocentric Castleman Disease' (OligoCD) has been found to be a distinct clinical entity, different from the two previously identified classifications of Castleman Disease. The findings redefine the understanding of this rare immune disorder that affects an estimated 4,300 to 5,200 Americans. Tue, 22 Apr 2025 13:15:31 EDT https://www.sciencedaily.com/releases/2025/04/250422131531.htm https://www.sciencedaily.com/releases/2025/04/250421163231.htm A new study asked three questions about muscle protein synthesis in response to a nine-day diet and weight training regimen: First, does the source of protein -- plant or animal-based -- make any difference to muscle gain? Second, does it matter if total daily protein intake is evenly distributed throughout the day? And third, does a moderate but sufficient daily protein intake influence any of these variables? The answer to all three questions is 'no,' the researchers found. Mon, 21 Apr 2025 16:32:31 EDT https://www.sciencedaily.com/releases/2025/04/250421163231.htm https://www.sciencedaily.com/releases/2025/04/250409114710.htm Scientists have rebuilt, in laboratory glassware, the neural pathway that sends information from the body's periphery to the brain, promising to aid research on pain disorders. Wed, 09 Apr 2025 11:47:10 EDT https://www.sciencedaily.com/releases/2025/04/250409114710.htm https://www.sciencedaily.com/releases/2025/04/250408191656.htm Scientists have helped identify a novel drug compound that selectively activates pain-altering receptors in the body, offering a potentially safer alternative to conventional pain medications. Tue, 08 Apr 2025 19:16:56 EDT https://www.sciencedaily.com/releases/2025/04/250408191656.htm https://www.sciencedaily.com/releases/2025/04/250408122115.htm Researchers conducted a large-scale epidemiological study to explore the potential health benefits of high muscle strength in preventing type 2 diabetes (T2D) across varying levels of genetic risk. The study found that higher muscle strength was associated with over 40% lower risk of T2D, regardless of genetic susceptibility to T2D. The study highlights the importance of maintaining or improving muscle strength as a key strategy for preventing T2D. Tue, 08 Apr 2025 12:21:15 EDT https://www.sciencedaily.com/releases/2025/04/250408122115.htm https://www.sciencedaily.com/releases/2025/04/250408121327.htm In the first comprehensive, cell-by-cell analysis of brain tissue from individuals with Tourette syndrome, researchers have pinpointed exactly which cells are perturbed and how they malfunction, revealing how different types of brain cells are affected by the condition. Findings from this groundbreaking study provide unprecedented insights into the interplay of different brain cell types in Tourette syndrome, suggesting new therapeutic directions. Tue, 08 Apr 2025 12:13:27 EDT https://www.sciencedaily.com/releases/2025/04/250408121327.htm https://www.sciencedaily.com/releases/2025/04/250407173105.htm Eight weeks of mindfulness or cognitive behavioral therapy were associated with improved pain, physical function and quality of life and reduced daily opioid dose in adults with chronic low back pain that required treated with daily opioids, according to a new study. This is one of the largest studies to date to evaluate mindfulness and cognitive behavioral therapy as treatment for opioid-treated chronic pain. Mon, 07 Apr 2025 17:31:05 EDT https://www.sciencedaily.com/releases/2025/04/250407173105.htm https://www.sciencedaily.com/releases/2025/03/250326122932.htm A team has discovered a possible therapeutic approach to repair injured muscles either from aging or degenerative muscle disorders. Wed, 26 Mar 2025 12:29:32 EDT https://www.sciencedaily.com/releases/2025/03/250326122932.htm https://www.sciencedaily.com/releases/2025/03/250318141359.htm A study has shown that lymph node transfer is a viable treatment for the swelling in the affected limb, a condition known as lymphedema, after breast cancer surgery. However, an effective drug to improve the outcomes of the transfer treatment continues to be sought. Tue, 18 Mar 2025 14:13:59 EDT https://www.sciencedaily.com/releases/2025/03/250318141359.htm https://www.sciencedaily.com/releases/2025/03/250317160418.htm A new study may help to explain why there is an over-representation of women experiencing chronic pain compared to men and why pain medication may not be as effective for women as it is for men. Findings show, male and females develop pain through different means. Mon, 17 Mar 2025 16:04:18 EDT https://www.sciencedaily.com/releases/2025/03/250317160418.htm https://www.sciencedaily.com/releases/2025/03/250314113601.htm When the brain doesn't know what to expect we perceive pain to be worse, a new study shows. The study may help shape more effective ways to manage pain in the future. Fri, 14 Mar 2025 11:36:01 EDT https://www.sciencedaily.com/releases/2025/03/250314113601.htm https://www.sciencedaily.com/releases/2025/03/250313130758.htm Neuroscientists have shown that experiencing nature can alleviate acute physical pain. Surprisingly, simply watching nature videos was enough to relieve pain. Using functional magnetic resonance imaging, the researchers found that acute pain was rated as less intense and unpleasant when watching nature videos -- along with a reduction in brain activity associated with pain. The results suggest that nature-based therapies can be used as promising complementary approaches to pain management. Thu, 13 Mar 2025 13:07:58 EDT https://www.sciencedaily.com/releases/2025/03/250313130758.htm https://www.sciencedaily.com/releases/2025/03/250313130310.htm Study uncovers new insights into pain pathways associated with temporomandibular joint (TMJ) disorders. Using an innovative in vivo imaging tool to capture functional activity in mouse models of TMJ injury and inflammation, the discovery could pave the way for more effective treatments for the millions affected by TMJ-related facial pain. Thu, 13 Mar 2025 13:03:10 EDT https://www.sciencedaily.com/releases/2025/03/250313130310.htm https://www.sciencedaily.com/releases/2025/03/250312165829.htm A recently completed study found that certain terpenes in Cannabis sativa are effective at relieving post-surgical and fibromyalgia pain in preclinical models. Wed, 12 Mar 2025 16:58:29 EDT https://www.sciencedaily.com/releases/2025/03/250312165829.htm https://www.sciencedaily.com/releases/2025/03/250312124012.htm MIS-C is a serious inflammatory shock that affects children. It can occur several weeks after a COVID infection and can be life-threatening. Until now, however, the precise cause of the condition was unknown. Researchers have identified that reactivation of a pre-existing, dormant infection with the Epstein-Barr virus triggers an excessive inflammatory response. These insights open the door to new treatment methods, potentially not limited to MIS-C. Wed, 12 Mar 2025 12:40:12 EDT https://www.sciencedaily.com/releases/2025/03/250312124012.htm